Venture Capital Investors
Merck
Merck provides venture capital investment to companies focused on high-impact, technology-driven solutions.
Venture Investor Overview
Investor Type
Venture Capital
Industry Focus
Biopharmaceutical
Contact Information
Title
Chief Financial Officer
Mailing Address
Frankfurter Strasse 250
Darmstadt, 64293
DE
Background Information
Overview
As a vibrant science and technology company, we believe in science as a force for good. We make a positive difference in millions of people's lives. Discover how Merck uses science to drive human progress! We use cookies so that we can offer you the best possible website experience. This includes cookies which are necessary for the operation of the app and the website, as well as other cookies which are used solely for anonymous statistical purposes, for more comfortable website settings, or for the display of personalized content. You are free to decide in the Cookie Settings which categories you would like to permit. Please note that depending on what you select, the full functionality of the website may no longer be available. You may review and change your choices at any time. Further information can be found in our Privacy Statement.
Transaction History
Our records indicate that Merck invested in the VC transactions listed below. Dollar amounts are for the entire raise, which may include other investors.
8/8/2024
Series B
$120,000,000
8/17/2022
Series B
$221,000,000
Investor Contacts
Chief Financial Officer
Marcus Kuhner
Funds
No fund closings have been recorded for this company.
Portfolio Companies
Merck has invested in the companies below, according to our database records. If we are missing a portfolio company, please let us know.
Browse more venture capital investors:
Mercia's EIS Funds | Mercura Capital
Share this article
About Our VC Firm Database
The venture capital investor data above is provided by VentureDeal.com, a leading provider of venture capital transaction data.
Additional Resources for Entrepreneurs
